Recombinant ErbB2/Her2 (Trastuzumab Biosimilar) anticorps (PE)
Aperçu rapide pour Recombinant ErbB2/Her2 (Trastuzumab Biosimilar) anticorps (PE) (ABIN7867252)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- PE-conjugated Anti-Her2 (trastuzumab biosimilar) mAb
-
Isotype
- IgG1
-
-
anti-ErbB2/Her2 (Trastuzumab Biosimilar) antibody
Research Grade Reactivité: Humain FACS, ELISA Hôte: Humanized Monoclonal unconjugated Recombinant Antibody
anti-ErbB2/Her2 (Trastuzumab Biosimilar) antibodyReactivité: Humain FACS, ELISA, IHC Hôte: Lapin Chimeric 4D5-8 unconjugated Recombinant Antibody
-
-
Indications d'application
- Flow Cyt 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2°C-8°C for 6 months
-
Date de péremption
- 6 months
-
-
- ErbB2/Her2 (Trastuzumab Biosimilar)
-
Autre désignation
- trastuzumab biosimilar
-
Classe de substances
- Biosimilar
-
Sujet
-
Synonyms: ERBB2,CD340,HER-2/neu,HER2,MLN19,NEU,NGL,TKR1,4D5-8,4D5V8,Herceptin,rhuMabHER2
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- P04626
Antigène
-
